The company, through its wholly-owned subsidiary, Isotropic Imaging Corp. is engaged in the development and commercialization of the "Isotropic Breast Imaging System" for application in proprietary diagnostic products for breast cancer, to address the demand by the breast imaging medical community for a cost-effective, true 3-D breast imaging technology, that improves patient comfort and delivers high diagnostic accuracy.